首页|宏基因组二代测序诊断免疫缺陷患者感染性疾病的研究进展

宏基因组二代测序诊断免疫缺陷患者感染性疾病的研究进展

扫码查看
宏基因组二代测序(mNGS)通过识别临床样本中的微生物核酸来协助诊断,是用于免疫功能低下患者感染性疾病诊断的有效工具。mNGS能够在常规检测为阴性的患者中识别出致病生物体,但目前在免疫力低下患者中,评估mNGS诊断感染效能的报告仅限于个体患者或小型回顾性研究。本文回顾分析文献,为在临床中开展mNGS相关研究提供新思路。
Research progress of infectious diseases in immunocompromised hosts using metagenomic next generation sequencing-based diagnostics
Metagenomic next generation sequencing(mNGS)based diagnostics that identify mi-crobial nucleic acids in clinical samples may be a useful tool in addressing some of these challenges.Studies of mNGS in immunocompromised hosts have demonstrated that these diagnostics are capable of identifying causative organisms in a subset of patients for whom conventional testing has been negative.But the reports evaluating the diagnostic efficiency of mNGS in immunocompromised patients are limit-ed to individual patients or small retrospective studies at present.This article reviewed and analyzed the literature to provide new ideas for conducting related research on mNGS in clinical practice.

immune dysfunctioninfectious diseasespathogensmetagenomic next generation sequencingliquid biopsyinfection surveillance

杨震宇、於江泉

展开 >

扬州大学,江苏扬州,225009

扬州大学第七临床医学院/靖江市人民医院急诊科,江苏靖江,214500

扬州大学临床医学院/扬州大学附属苏北人民医院重症医学科,江苏扬州,225000

免疫功能不全 感染性疾病 病原体 宏基因组二代测序 液体活检 感染监测

江苏省医学重点学科建设单位基金(十四五)江苏省扬州市社会发展项目

JSDW202217YZ2023105

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(9)
  • 33